NCT04319237 2026-03-02
Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes
H. Lee Moffitt Cancer Center and Research Institute
Completed
Clinical Trials
3 trialsNCT04531709 2025-07-14
Financial Toxicity and Quality of Life in Patients With TGCT
The University of Texas Health Science Center at San Antonio
Completed
NCT05100277 2022-01-06
Impact of Oncotype DX® on Treatment Recommendation and Its Economic Evaluation Under the Brazilian Society Perspective
Hospital Perola Byington
Completed